Rifnote
Loading your desk
July 28, 2026
World
SCSouth China Morning Post
SCSouth China Morning Post
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health…
Two US-developed treatments for breast cancer and a degenerative eye disease will undergo large-scale clinical trials in the Greater Bay Area in a collaboration involving Hong Kong, Shenzhen and a pharmaceutical start-up founded by a former lawmaker. The agreement was formalised on Tuesday when Health…
This story was indexed from the original publisher.
Read at South China Morning Post